NCT04191629 is a Phase 1 clinical trial of EO1404 in Corneal Edema, sponsored by Valeria Sanchez-Huerta.

Who is sponsoring NCT04191629?

NCT04191629 is sponsored by Valeria Sanchez-Huerta.

What drugs are being tested in NCT04191629?

Interventions in NCT04191629: EO1404, Endothelial brushing or Descemet stripping.

What condition does NCT04191629 study?

NCT04191629 studies Corneal Edema, Fuchs Dystrophy, Fuchs' Endothelial Dystrophy, Pseudophakic Bullous Keratopathy, Corneal Endothelial Dystrophy, Corneal Transplant Failure.

Is NCT04191629 still recruiting?

NCT04191629 is currently status unknown. Last updated 10 December 2019.

Last reviewed 2019-12-10 · How we verify

NCT04191629

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema

Status unknown Phase 1 Last updated 10 December 2019

What this trial tests

Phase 1 trial testing EO1404 in Corneal Edema in 35 participants. Status unknown.

Timeline

4 May 2016

Primary endpoint
31 December 2020

28 February 2021

Quick facts

Lead sponsor	Valeria Sanchez-Huerta
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	4 May 2016
Primary completion	31 December 2020
Estimated completion	28 February 2021
Sites	1 location across Mexico

Drugs / interventions tested

EO1404
Endothelial brushing or Descemet stripping

Conditions studied

Corneal Edema — all drugs for Corneal Edema →
Fuchs Dystrophy — all drugs for Fuchs Dystrophy →
Fuchs' Endothelial Dystrophy — all drugs for Fuchs' Endothelial Dystrophy →
Pseudophakic Bullous Keratopathy — all drugs for Pseudophakic Bullous Keratopathy →

Sponsor

Valeria Sanchez-Huerta

Who can join

21 and older, any sex, with Corneal Edema or Fuchs Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single center, phase 1 study to evaluate the safety and tolerability of EO1404 in subjects with corneal edema secondary to pseudophakic bullous keratopathy or Fuch's endothelial dystrophy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Corneal Edema

Currently open trials in the same condition.

NCT06261346 — Plasma Rich in Growth Factors in Corneal Endothelial Transplantation · NA · recruiting
NCT06983652 — Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema · recruiting
NCT05636579 — Study to Assess Safety and Tolerability of Multiple Doses of EO2002 · Phase 1 · recruiting
NCT05436665 — The Belgian Endothelial Surgical Transplant of the Cornea · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04191629 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Valeria Sanchez-Huerta
Last refreshed: 10 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04191629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing